相关实验视频

Updated: Jun 19, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

复发性/耐药性MCL的治疗方法

Elisabeth Silkenstedt¹, Martin Dreyling¹

¹Department of Medicine III, Ludwig Maximilian University Hospital, Munich, Germany.

|July 26, 2024

概括

膜细胞淋巴瘤 (MCL) 治疗正在通过向疗法发展. 结合布鲁顿氨酸激酶 (BTK) 抑制剂和免疫治疗的新策略为复发性/耐药性MCL患者提供了希望.

科学领域:

血液学血液学血液学
在瘤学瘤学.
免疫治疗是一种免疫疗法.

背景情况:

薄膜细胞淋巴瘤 (MCL) 是一种罕见的B细胞非霍奇金淋巴瘤,具有可变的临床行为.
目前针对复发性/耐药性 (R/R) MCL的治疗方法存在局限性,特别是在对布鲁顿氨酸激酶 (BTK) 抑制剂耐药的患者中.
尽管取得了进展,但R/R MCL的长期预后仍然很差.

研究的目的:

审查R/R MCL的当前和新兴治疗选择.
突出结合针对性和免疫治疗策略的作用.
讨论治疗预后有限的患者的新方法.

主要方法:

对R/R MCL的当前和新兴疗法的文献综述.
专注于联合向治疗 (BTK 抑制剂,BCL2 抑制剂).
探索免疫治疗方法 (CAR T细胞,双特异性抗体).

主要成果:

针对性和免疫治疗方法正在改善R/R MCL的结果.
包括BTK和BCL2抑制剂在内的联合策略显示出有前途.
化学抗原受体T细胞和双特异性抗体是新兴的选择.

结论:

新的治疗策略对于改善R/R MCL的结果至关重要.
组合疗法和免疫疗法为患者提供了新的希望,特别是那些BTK抑制剂耐药的人.
对这些先进疗法的进一步研究是有必要的,以克服长期预后的局限性.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.